We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
HSBC
HSBC
$353B
| $8.46M | 0.02% |
323,539
| – | – |
|
477
FirstEnergy
FE
$28.4B
| $8.46M | 0.02% |
237,399
+44,423
| +23% | +$1.69M |
|
478
Teradyne
TER
$51.7B
| $8.32M | 0.02% |
76,226
+50,267
| +194% | +$6.11M |
|
479
Ecolab
ECL
$79.3B
| $8.28M | 0.02% |
39,682
-3,761
| -9% | -$824K |
|
480
Halozyme
HALO
$9.9B
| $8.26M | 0.02% |
203,043
+49,732
| +32% | +$2.08M |
|
481
Generac Holdings
GNRC
$11.6B
| $8.23M | 0.02% |
20,131
+2,530
| +14% | +$1.08M |
|
482
Omnicom Group
OMC
$23.7B
| $8.2M | 0.02% |
113,141
-15,820
| -12% | -$1.18M |
|
483
Allstate
ALL
$70.2B
| $8.19M | 0.02% |
64,357
-25,586
| -28% | -$3.38M |
|
484
DaVita
DVA
$15.4B
| $8.18M | 0.02% |
70,360
-1,741
| -2% | -$218K |
|
485
Manhattan Associates
MANH
$12.3B
| $8.11M | 0.02% |
52,965
-350
| -0.7% | -$54.6K |
|
486
Penumbra
PEN
$12.6B
| $8.07M | 0.02% |
30,300
| – | – |
|
487
ON Semiconductor
ON
$31.6B
| $8.07M | 0.02% |
176,270
+136,100
| +339% | +$5.82M |
|
488
Builders FirstSource
BLDR
$7.38B
| $8.05M | 0.02% |
155,700
-2,920
| -2% | -$143K |
|
489
Regions Financial
RF
$26.4B
| $8.02M | 0.02% |
376,395
+211,645
| +128% | +$4.21M |
|
490
WEC Energy
WEC
$36.2B
| $7.97M | 0.02% |
90,336
-8,756
| -9% | -$821K |
|
|
SGI
491
Somnigroup International
SGI
$14.4B
| $7.92M | 0.02% |
170,558
-10,985
| -6% | -$480K |
|
492
Trade Desk
TTD
$9.04B
| $7.88M | 0.02% |
112,091
+55,695
| +99% | +$4.31M |
|
493
Bunge Global
BG
$21.1B
| $7.86M | 0.02% |
96,690
+14,620
| +18% | +$1.13M |
|
494
Hubbell
HUBB
$24.4B
| $7.79M | 0.02% |
43,122
-355
| -0.8% | -$69.2K |
|
495
Capri Holdings
CPRI
$1.83B
| $7.79M | 0.02% |
160,915
+25,050
| +18% | +$1.36M |
|
496
RPM International
RPM
$13.8B
| $7.78M | 0.02% |
100,228
| – | – |
|
497
Reliance Steel & Aluminium
RS
$20.6B
| $7.76M | 0.02% |
54,498
-12,175
| -18% | -$1.83M |
|
|
CDAK
498
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $7.74M | 0.02% |
474,007
-176,505
| -27% | -$3.16M |
|
|
SNV
499
DELISTED
Synovus
SNV
| $7.72M | 0.02% |
175,798
+22,200
| +14% | +$939K |
|
500
Travelers Companies
TRV
$80.9B
| $7.7M | 0.02% |
50,650
+17,863
| +54% | +$2.77M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.